Randomized Phase III Multicenter Trial of RRM1 & ERCC1 Directed Customized Chemotherapy Versus Standard of Care for 1st Line Treatment of Patients With Advanced Non-Small-Cell Lung Cancer.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Carboplatin; Docetaxel; Gemcitabine; Vinorelbine
- Indications Non-small cell lung cancer
- Focus Pharmacogenomic; Registrational; Therapeutic Use
- Acronyms MADeIT
- 09 Jul 2014 Biomarkers information updated
- 31 May 2013 Primary endpoint 'Progression-free-survival-rate' has not been met.
- 31 May 2013 Results presented at the 49th Annual Meeting of the American Society of Clinical Oncology.